\begin{tabular}{llcclcclcclcclcc} 
\toprule
\multirow{3}{*}{Analysis} & \multirow{3}{*}{Coefficient} & \multicolumn{11}{c}{\textit{ACE}} & & \multicolumn{2}{c}{\textit{ACE2}} \\ 
\cmidrule{3-13}\cmidrule{15-16}
 & & \multicolumn{2}{c}{cg09920557} & & \multicolumn{2}{c}{cg19802564} & & \multicolumn{2}{c}{cg21094739} & & \multicolumn{2}{c}{cg10468385} & & \multicolumn{2}{c}{cg08559914{$^1$}} \\
 & & Estimate (SE) & P-value & & Estimate (SE) & P-value & & Estimate (SE) & P-value & & Estimate (SE) & P-value & & Estimate (SE) & P-value \\ 
\midrule
Overall & \texttt{Intercept} & \begin{tabular}[c]{@{}c@{}}$-$3.769\\(0.065)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.551\\(0.081)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.938\\(0.096)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}3.082\\(0.100)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}2.035\\(0.078)\end{tabular} & <0.001 \\
 & \texttt{Disease status:ME/CFS} & \begin{tabular}[c]{@{}c@{}}$-$0.060\\(0.092)\end{tabular} & 0.519 & & \begin{tabular}[c]{@{}c@{}}$-$0.016\\(0.115)\end{tabular} & 0.889 & & \begin{tabular}[c]{@{}c@{}}$-$0.064\\(0.136)\end{tabular} & 0.638 & & \begin{tabular}[c]{@{}c@{}}$-$0.118\\(0.142)\end{tabular} & 0.409 & & \begin{tabular}[c]{@{}c@{}}$-$0.141\\(0.048)\end{tabular} & 0.004 \\
 & \texttt{Study:de Vega et al.(2017)} & \begin{tabular}[c]{@{}c@{}}$-$2.367\\(0.079)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}0.7071\\(0.098)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.419\\(0.116)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}2.437\\(0.121)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.703\\(0.085)\end{tabular} & <0.001 \\
 & \texttt{Study:Trivedi et al.(2018)}{$^2$} & \begin{tabular}[c]{@{}c@{}}0.145\\(0.092)\end{tabular} & 0.117 & & --- & --- & & --- & --- & & \begin{tabular}[c]{@{}c@{}}$-$0.625\\(0.142)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}$-$0.88672\\(0.10334)\end{tabular} & <0.001 \\
 & \texttt{Study:Herrera et al.(2018)} & \begin{tabular}[c]{@{}c@{}}$-$2.245\\(0.073)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}0.425\\(0.091)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}0.740\\(0.107)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.772\\(0.112)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.270\\(0.082)\end{tabular} & <0.001 \\
 & \begin{tabular}[c]{@{}l@{}}\texttt{Disease status:ME/CFS}$\times$\\ \texttt{Study:de Vega et al.(2017)}\end{tabular} & \begin{tabular}[c]{@{}c@{}}0.131\\(0.108)\end{tabular} & 0.224 & & \begin{tabular}[c]{@{}c@{}}$-$0.107\\(0.133)\end{tabular} & 0.425 & & \begin{tabular}[c]{@{}c@{}}$-$0.198\\(0.158)\end{tabular} & 0.210 & & \begin{tabular}[c]{@{}c@{}}$-$0.159\\(0.165)\end{tabular} & 0.336 & & --- & --- \\
 & \begin{tabular}[c]{@{}l@{}}\texttt{Disease status:ME/CFS}$\times$\\ \texttt{Study:Trivedi et al.(2018)}\end{tabular} & \begin{tabular}[c]{@{}c@{}}$-$0.315\\(0.130)\end{tabular} & 0.016 & & --- & --- & & --- & --- & & \begin{tabular}[c]{@{}c@{}}0.264\\(0.199)\end{tabular} & 0.186 & & --- & --- \\
 & \begin{tabular}[c]{@{}l@{}}\texttt{Disease status:ME/CFS}$\times$\\ \texttt{Study:Herrera et al.(2018)}\end{tabular} & \begin{tabular}[c]{@{}c@{}}0.048\\(0.102)\end{tabular} & 0.638 & & \begin{tabular}[c]{@{}c@{}}0.072\\(0.127)\end{tabular} & 0.571 & & \begin{tabular}[c]{@{}c@{}}0.157\\(0.150)\end{tabular} & 0.295 & & \begin{tabular}[c]{@{}c@{}}0.181\\(0.157)\end{tabular} & 0.250 & & --- & --- \\ 
\midrule
 % &  &  & & & & & & \\
Females & \texttt{Intercept} & \begin{tabular}[c]{@{}c@{}}$-$3.769\\(0.068)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.406\\(0.107)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.938\\(0.093)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}3.082\\(0.092)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}2.035\\(0.068)\end{tabular} & <0.001 \\
 & \texttt{Disease status:ME/CFS} & \begin{tabular}[c]{@{}c@{}}$-$0.060\\(0.096)\end{tabular} & 0.535 & & \begin{tabular}[c]{@{}c@{}}$-$0.224\\(0.152)\end{tabular} & 0.143 & & \begin{tabular}[c]{@{}c@{}}$-$0.064 \\(0.132)\end{tabular} & 0.629 & & \begin{tabular}[c]{@{}c@{}}$-$0.117 \\(0.130)\end{tabular} & 0.366 & & \begin{tabular}[c]{@{}c@{}}$-$0.141 \\(0.045)\end{tabular} & 0.002 \\
 & \texttt{Study:de Vega et al.(2017)} & \begin{tabular}[c]{@{}c@{}}$-$2.367 \\(0.082)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}0.499 \\(0.130)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.419 \\(0.113)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}2.437 \\(0.111)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.703 \\(0.075)\end{tabular} & <0.001 \\
 &  \texttt{Study:Trivedi et al.(2018)}{$^2$} & \begin{tabular}[c]{@{}c@{}}0.145 \\(0.096)\end{tabular} & 0.131 & & --- & --- & & --- & --- & & \begin{tabular}[c]{@{}c@{}}$-$0.625 \\(0.130)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}$-$0.887\\(0.090)\end{tabular} & <0.001 \\
 & \texttt{Study:Herrera et al.(2018)} & \begin{tabular}[c]{@{}c@{}}$-$2.238 \\(0.079)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}$-$0.233 \\(0.124)\end{tabular} & 0.062 & & \begin{tabular}[c]{@{}c@{}}0.770 \\(0.108)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.786 \\(0.106)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.379 \\(0.073)\end{tabular} & <0.001 \\
 & \begin{tabular}[c]{@{}l@{}}\texttt{Disease status:ME/CFS}$\times$\\ \texttt{Study:de Vega et al.(2017)}\end{tabular} & \begin{tabular}[c]{@{}c@{}}0.131 \\(0.112)\end{tabular} & 0.241 & & \begin{tabular}[c]{@{}c@{}}$-$0.112 \\(0.177)\end{tabular} & 0.526 & & \begin{tabular}[c]{@{}c@{}}$-$0.198 \\(0.153)\end{tabular} & 0.198 & & \begin{tabular}[c]{@{}c@{}}$-$0.159 \\(0.151)\end{tabular} & 0.293 & & --- & --- \\
 & \begin{tabular}[c]{@{}l@{}}\texttt{Disease status:ME/CFS}$\times$\\ \texttt{Study:Trivedi et al.(2018)}\end{tabular} & \begin{tabular}[c]{@{}c@{}}$-$0.315 \\(0.134)\end{tabular} & 0.020 & & --- & --- & & --- & --- & & \begin{tabular}[c]{@{}c@{}}0.264 \\(0.182)\end{tabular} & 0.148 & & --- & --- \\
 & \begin{tabular}[c]{@{}l@{}}\texttt{Disease status:ME/CFS}$\times$\\ \texttt{Study:Herrera et al.(2018)}\end{tabular} & \begin{tabular}[c]{@{}c@{}}0.029\\(0.109)\end{tabular} & 0.791 & & \begin{tabular}[c]{@{}c@{}}0.258\\(0.173)\end{tabular} & 0.138 & & \begin{tabular}[c]{@{}c@{}}0.166\\(0.150)\end{tabular} & 0.270 & & \begin{tabular}[c]{@{}c@{}}0.241\\(0.148)\end{tabular} & 0.104 & & --- & --- \\
\bottomrule
\end{tabular}
% \begin{tabular}{llcclcclcclcclcc} 
% \toprule
% \multirow{3}{*}{Analysis} & \multirow{3}{*}{Coefficient} & \multicolumn{11}{c}{\textit{ACE}} & & \multicolumn{2}{c}{\textit{ACE2}} \\ 
% \cmidrule{3-13}\cmidrule{15-16}
%  & & \multicolumn{2}{c}{cg09920557} & & \multicolumn{2}{c}{cg19802564} & & \multicolumn{2}{c}{cg21094739} & & \multicolumn{2}{c}{cg10468385} & & \multicolumn{2}{c}{cg08559914{$^1$}} \\
%  & & Estimate (SE) & P-value & & Estimate (SE) & P-value & & Estimate (SE) & P-value & & Estimate (SE) & P-value & & Estimate (SE) & P-value \\ 
% \midrule
% Overall & \texttt{Intercept} & \begin{tabular}[c]{@{}c@{}}$-$3.769\\(0.065)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.551\\(0.081)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.938\\(0.096)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}3.082\\(0.100)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}2.035\\(0.078)\end{tabular} & <0.001 \\
%  & \texttt{Disease status:ME/CFS} & \begin{tabular}[c]{@{}c@{}}$-$0.060\\(0.092)\end{tabular} & 0.519 & & \begin{tabular}[c]{@{}c@{}}$-$0.016\\(0.115)\end{tabular} & 0.889 & & \begin{tabular}[c]{@{}c@{}}$-$0.064\\(0.136)\end{tabular} & 0.638 & & \begin{tabular}[c]{@{}c@{}}$-$0.118\\(0.142)\end{tabular} & 0.409 & & \begin{tabular}[c]{@{}c@{}}$-$0.141\\(0.048)\end{tabular} & 0.004 \\
%  & \texttt{Study:de Vega et al.(2017)} & \begin{tabular}[c]{@{}c@{}}$-$2.367\\(0.079)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}0.7071\\(0.098)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.419\\(0.116)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}2.437\\(0.121)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.703\\(0.085)\end{tabular} & <0.001 \\
%  & \texttt{Study:Trivedi et al.(2018)}{$^2$} & \begin{tabular}[c]{@{}c@{}}0.145\\(0.092)\end{tabular} & 0.117 & & \begin{tabular}[c]{@{}c@{}}NA\\(NA)\end{tabular} & NA & & \begin{tabular}[c]{@{}c@{}}NA\\(NA)\end{tabular} & NA & & \begin{tabular}[c]{@{}c@{}}$-$0.625\\(0.142)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}$-$0.88672\\(0.10334)\end{tabular} & <0.001 \\
%  & \texttt{Study:Herrera et al.(2018)} & \begin{tabular}[c]{@{}c@{}}$-$2.245\\(0.073)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}0.425\\(0.091)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}0.740\\(0.107)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.772\\(0.112)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.270\\(0.082)\end{tabular} & <0.001 \\
%  & \begin{tabular}[c]{@{}l@{}}\texttt{Disease status:ME/CFS}$\times$\\ \texttt{Study:de Vega et al.(2017)}\end{tabular} & \begin{tabular}[c]{@{}c@{}}0.131\\(0.108)\end{tabular} & 0.224 & & \begin{tabular}[c]{@{}c@{}}$-$0.107\\(0.133)\end{tabular} & 0.425 & & \begin{tabular}[c]{@{}c@{}}$-$0.198\\(0.158)\end{tabular} & 0.210 & & \begin{tabular}[c]{@{}c@{}}$-$0.159\\(0.165)\end{tabular} & 0.336 & & \begin{tabular}[c]{@{}c@{}}NA\\(NA)\end{tabular} & NA \\
%  & \begin{tabular}[c]{@{}l@{}}\texttt{Disease status:ME/CFS}$\times$\\ \texttt{Study:Trivedi et al.(2018)}\end{tabular} & \begin{tabular}[c]{@{}c@{}}$-$0.315\\(0.130)\end{tabular} & 0.016 & & \begin{tabular}[c]{@{}c@{}}NA\\(NA)\end{tabular} & NA & & \begin{tabular}[c]{@{}c@{}}NA\\(NA)\end{tabular} & NA & & \begin{tabular}[c]{@{}c@{}}0.264\\(0.199)\end{tabular} & 0.186 & & \begin{tabular}[c]{@{}c@{}}NA\\(NA)\end{tabular} & NA \\
%  & \begin{tabular}[c]{@{}l@{}}\texttt{Disease status:ME/CFS}$\times$\\ \texttt{Study:Herrera et al.(2018)}\end{tabular} & \begin{tabular}[c]{@{}c@{}}0.048\\(0.102)\end{tabular} & 0.638 & & \begin{tabular}[c]{@{}c@{}}0.072\\(0.127)\end{tabular} & 0.571 & & \begin{tabular}[c]{@{}c@{}}0.157\\(0.150)\end{tabular} & 0.295 & & \begin{tabular}[c]{@{}c@{}}0.181\\(0.157)\end{tabular} & 0.250 & & \begin{tabular}[c]{@{}c@{}}NA\\(NA)\end{tabular} & NA \\ 
% \midrule
%  % &  &  & & & & & & \\
% Females & \texttt{Intercept} & \begin{tabular}[c]{@{}c@{}}$-$3.769\\(0.068)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.406\\(0.107)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.938\\(0.093)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}3.082\\(0.092)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}2.035\\(0.068)\end{tabular} & <0.001 \\
%  & \texttt{Disease status:ME/CFS} & \begin{tabular}[c]{@{}c@{}}$-$0.060\\(0.096)\end{tabular} & 0.535 & & \begin{tabular}[c]{@{}c@{}}$-$0.224\\(0.152)\end{tabular} & 0.143 & & \begin{tabular}[c]{@{}c@{}}$-$0.064 \\(0.132)\end{tabular} & 0.629 & & \begin{tabular}[c]{@{}c@{}}$-$0.117 \\(0.130)\end{tabular} & 0.366 & & \begin{tabular}[c]{@{}c@{}}$-$0.141 \\(0.045)\end{tabular} & 0.002 \\
%  & \texttt{Study:de Vega et al.(2017)} & \begin{tabular}[c]{@{}c@{}}$-$2.367 \\(0.082)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}0.499 \\(0.130)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.419 \\(0.113)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}2.437 \\(0.111)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.703 \\(0.075)\end{tabular} & <0.001 \\
%  &  \texttt{Study:Trivedi et al.(2018)}{$^2$} & \begin{tabular}[c]{@{}c@{}}0.145 \\(0.096)\end{tabular} & 0.131 & & \begin{tabular}[c]{@{}c@{}}NA \\(NA)\end{tabular} & NA & & \begin{tabular}[c]{@{}c@{}}NA \\(NA)\end{tabular} & NA & & \begin{tabular}[c]{@{}c@{}}$-$0.625 \\(0.130)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}$-$0.887\\(0.090)\end{tabular} & <0.001 \\
%  & \texttt{Study:Herrera et al.(2018)} & \begin{tabular}[c]{@{}c@{}}$-$2.238 \\(0.079)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}$-$0.233 \\(0.124)\end{tabular} & 0.062 & & \begin{tabular}[c]{@{}c@{}}0.770 \\(0.108)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.786 \\(0.106)\end{tabular} & <0.001 & & \begin{tabular}[c]{@{}c@{}}1.379 \\(0.073)\end{tabular} & <0.001 \\
%  & \begin{tabular}[c]{@{}l@{}}\texttt{Disease status:ME/CFS}$\times$\\ \texttt{Study:de Vega et al.(2017)}\end{tabular} & \begin{tabular}[c]{@{}c@{}}0.131 \\(0.112)\end{tabular} & 0.241 & & \begin{tabular}[c]{@{}c@{}}$-$0.112 \\(0.177)\end{tabular} & 0.526 & & \begin{tabular}[c]{@{}c@{}}$-$0.198 \\(0.153)\end{tabular} & 0.198 & & \begin{tabular}[c]{@{}c@{}}$-$0.159 \\(0.151)\end{tabular} & 0.293 & & \begin{tabular}[c]{@{}c@{}}NA \\(NA)\end{tabular} & NA \\
%  & \begin{tabular}[c]{@{}l@{}}\texttt{Disease status:ME/CFS}$\times$\\ \texttt{Study:Trivedi et al.(2018)}\end{tabular} & \begin{tabular}[c]{@{}c@{}}$-$0.315 \\(0.134)\end{tabular} & 0.020 & & \begin{tabular}[c]{@{}c@{}}NA \\(NA)\end{tabular} & NA & & \begin{tabular}[c]{@{}c@{}}NA \\(NA)\end{tabular} & NA & & \begin{tabular}[c]{@{}c@{}}0.264 \\(0.182)\end{tabular} & 0.148 & & \begin{tabular}[c]{@{}c@{}}NA\\(NA)\end{tabular} & NA \\
%  & \begin{tabular}[c]{@{}l@{}}\texttt{Disease status:ME/CFS}$\times$\\ \texttt{Study:Herrera et al.(2018)}\end{tabular} & \begin{tabular}[c]{@{}c@{}}0.029\\(0.109)\end{tabular} & 0.791 & & \begin{tabular}[c]{@{}c@{}}0.258\\(0.173)\end{tabular} & 0.138 & & \begin{tabular}[c]{@{}c@{}}0.166\\(0.150)\end{tabular} & 0.270 & & \begin{tabular}[c]{@{}c@{}}0.241\\(0.148)\end{tabular} & 0.104 & & \begin{tabular}[c]{@{}c@{}}NA\\(NA)\end{tabular} & NA \\
% \bottomrule
% \end{tabular}